Pharma R&D model no help to developing countries
May 22, 2012Research and Development, Sales and Marketing HIV, MSF, Médecins Sans Frontières, R&D
Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …
Pfizer cutting 40% of Premarin plant workforce
May 22, 2012Manufacturing and Production
Pfizer has said it plans to cut 40% of jobs at a manufacturing facility in Manitoba, Canada, that supplies the …
Sir Gordon Duff to host this year’s Clinical Discovery Annual Conference
May 22, 2012Medical Communications, Sales and Marketing
Events 4 Healthcare is delighted that Sir Gordon Duff will be chairing this year’s Clinical Discovery Annual Conference on 16 …
Mitsubishi Tanabe exits API business
May 22, 2012Manufacturing and Production API, Mitsubishi, Phil Taylor, Tanabe
Mitsubishi Tanabe Pharma has said it will withdraw from the fine chemical business, including active pharmaceutical ingredient (API) supply, and …
Biotec strengthens team with new appointments
May 22, 2012Manufacturing and Production
Bridgend, Wales: Biotec Services International has announced the appointment of two senior industry professionals as the company embarks on an …
UCB signs new epilepsy research pact with Imperial
May 21, 2012Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy
UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …
ICON makes two senior appointments
May 21, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRO, ICON, appointment
ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research. …
Ovarian cancer charity wins GSK/King’s Fund award
May 21, 2012Medical Communications, Sales and Marketing GSK, awards, charity, king's fund, ovarian cancer
A charity which aims to increase the chances of survival for patients with a poorly-treated form of cancer is to …
World’s first stem cell drug approved in Canada
May 21, 2012Sales and Marketing Canada, regenerative medicine, stem cell
Canada has approved the world’s first stem cell drug, marking an historic day for the burgeoning therapy. Osiris’ Prochymal is …
GSK buys more of Theravance
May 18, 2012Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance
GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …
OPEN Health invests in Harvey Walsh
May 18, 2012Medical Communications Harvey Walsh, Open Health
Harvey Walsh, a market access and healthcare intelligence company, is to join forces with OPEN Health, the healthcare communications group. OPEN Health …
Teva re-elects Chairman of the Board
May 18, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frost, Teva
Teva has announced that its Board of Directors has unanimously voted to re-elect Dr Phillip Frost as Chairman of the …
Plavix loses US patent protection
May 18, 2012Sales and Marketing BMS, FDA, Lipitor, Pfizer, Plavix, Sanofi
Sanofi and Bristol-Myers Squibb’s blood thinner Plavix has lost its patent protection in the US. The drug, which made $6.6 …
NICE to be sidelined on cost effectiveness – once again
May 17, 2012Sales and Marketing NICE, VBP
Health secretary Andrew Lansley has confirmed that NICE will no longer direct the NHS on the cost effectiveness of drugs. …
NICE comes out fighting against appraisal delays story
May 17, 2012Sales and Marketing Daily Mail, Dillon, NHS, NICE, Pfizer, Victrelis
NICE has criticised a report that says the watchdog has taken up to nine years to appraise certain drugs. The …
Medivir appoints commercial executive vice president
May 17, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Juserius, Medivir
Research-based speciality firm Medivir has appointed Henric Juserius to be the new head of the company’s commercial activities. Juserius who …
Torisel fails in head-to-head study with Nexavar
May 16, 2012Research and Development, Sales and Marketing Bayer, Nexavar, Pfizer, Torisel, inlyta, rcc
Pfizer’s kidney cancer drug Torisel has failed to best Bayer’s Nexavar in a head-to-head trial. The Phase III study was …
Pharma funds drug discovery partnership
May 16, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dundee, MRC, drug discovery, funding, partnerships, pharma
Half a dozen pharma firms are contributing £14.4 million to work by Dundee University and the Medical Research Council (MRC) on …
Merck KGaA’s colon cancer drug fails trial
May 16, 2012Research and Development, Sales and Marketing Erbitux, Merck KGaA, Merck Serono, colon cancer
Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial. …
Capturing the Brazilian pharma opportunity
May 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma
Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
